Wolfgang Wienand of Lonza and Kevin Trivett of Eli Lilly headline the conference, offering perspectives on manufacturing the next generation of medicine and scaling technology for patient access. They will be joined by Marla Phillips, who will address the intersection of artificial intelligence and human oversight, and cancer advocate Jamie Valvano, who provides a personal lens on the impact of medical research. The program also features a Global Regulatory Town Hall on October 21, where leaders will dissect the role of data and surveillance in modern compliance.
In section Releases
ISPE Unveils 2026 Annual Meeting Keynote Lineup in Washington D.C.
The International Society for Pharmaceutical Engineering has finalized its keynote roster for the 2026 Annual Meeting & Expo, set for October 18–21 in Washington, D.C. The event will spotlight shifts in biopharmaceutical manufacturing, bridging the divide between rapid digital transformation and the human-centric delivery of global patient therapies.

Organizers have structured the agenda around five core tracks, ranging from digital integrity to sustainable operations. Connie Langer, the program committee chair and Pfizer executive, noted that these sessions function as a unified narrative, tracing the trajectory of innovation from initial research to final clinical application. Beyond the keynote stage, the schedule includes interactive workshops on October 18, an emerging leader hackathon, and a facility tour of the AstraZeneca Commercial Cell Therapy site, reinforcing the focus on real-world manufacturing challenges.
Comments (0)
No comments yet. Be the first!